QR-Code

Exploring the comparative cardiovascular death benefits of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring

Background and aimsCardiovascular death (CV death) is the most objective component of the primary or secondary endpoint in cardiovascular outcome trials (CVOTs) conducted with sodium–glucose cotransporter 2 inhibitors (SGLT-2is). CV death is often incorporated into primary composite outcomes. It is...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Samit Ghosal, Binayak Sinha
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2023-07-01
Schriftenreihe:Frontiers in Endocrinology
Schlagworte:
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fendo.2023.1168755/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!